ContraFect

ContraFect EPS

The Earnings per Share (EPS) of ContraFect (CFRXQ) as of Oct 19, 2026 is -125.29 USD. In the previous year, Earnings per Share (EPS) was -44.09 USD — a change of 184.18% (lower).

EPS

-125.29USD

YoY

184.18%

Last updated:

Earnings per Share (EPS) of ContraFect is 2022 -125.29 USD. Earnings per Share (EPS) of ContraFect was 2021 -44.09 USD. It decreases by 184.18% lower compared to the previous year.

The ContraFect EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2018
-376.80 USD
Jan 1, 2019
-127.90 USD
Jan 1, 2020
-100.57 USD
Jan 1, 2021
-44.09 USD
Jan 1, 2022
-125.29 USD
Jan 1, 2023 (e)
-3.54 USD
Jan 1, 2024 (e)
-1.55 USD
Jan 1, 2025 (e)
-1.14 USD
The ContraFect EPS history
YEAREPSYoY
est-1.14USD-26.00%
est-1.55USD-56.40%
est-3.54USD-97.17%
-125.29USD+184.18%
-44.09USD-56.16%
-100.57USD-21.37%
-127.90USD-66.06%
-376.80USD+69.95%
-221.71USD-68.93%
-713.50USD-14.79%
-837.33USD-75.81%
-3,462.00USD+193.14%
-1,181.00USD+22.51%
-964.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ContraFect Stock analysis

What does ContraFect do? ContraFect Corp, based in Yonkers, New York, is a clinical-stage biotechnology company focused on developing direct lytic agents (DLAs) such as lysins and amurin peptides to treat life-threatening antibiotic-resistant infections. The company, listed in 2014, employs 23 people and is advancing its lead candidate exebacase (CF-301) for MRSA bloodstream infections and chronic prosthetic joint infections, alongside CF-370 targeting gram-negative bacteria. ContraFect is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ContraFect stock

Earnings per Share (EPS) of ContraFect is -125.29 USD in 2022.

Earnings per Share (EPS) of ContraFect changed from -44.09 USD to -125.29 USD, representing a 184.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) ContraFect since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — ContraFect

All Key Metrics — ContraFect